Richard Daverman

Editor

Latest from Richard Daverman

Asian currency
Innovation
Eyes on Asia: Astellas bags gene therapy, AZ a lipoprotein, and a Japanese incubatorAstellas bags gene therapy, AZ a lipoprotein, and a Japanese incubator
byRichard Daverman
Oct 21, 2024
4 Min Read
Eli Lilly logo
Innovation
From east to west: Lilly plans incubators in China and UKFrom east to west: Lilly plans incubators in China and UK
byMillie Nelson, Richard Daverman
Oct 18, 2024
2 Min Read

All from Richard Daverman

Hubs
Eyes on Asia: News from Sanofi, Bayer, AZ plus the return of VC?
News from Sanofi, Bayer, AZ plus the return of VC?
Sep 29, 2024
|
2 Min Read
byRichard Daverman
Hubs
Eyes on Asia: Shinyaku’s $735m DMD deal, Kite turns back in China, and more
Shinyaku’s $735m DMD deal, Kite turns back in China, and more
Sep 23, 2024
|
2 Min Read
byRichard Daverman
Chinese flag — Photo
Investment
China biopharma faces a pause; how bad is it?
China biopharma mid-2023 market summary
Sep 21, 2024
|
4 Min Read
byRichard Daverman
Investment
Eyes on Asia: Eisai $1.5bn pact, OcuMension & Alcon, TYK IPO and more
Eyes on Asia: Eisai $1.5bn pact, OcuMension & Alcon, TYK IPO and more
Sep 18, 2024
|
4 Min Read
byRichard Daverman
Partnering
Top five Asia biopharma deals: August 2024
Asia biopharma deals: August 2024
Sep 15, 2024
|
4 Min Read
byRichard Daverman
Partnering
Eyes on Asia: EpimAb sells T-cell, funding for TargetRx, Hygieai on the siRNA march
Eyes on Asia: News from EpimAb, TargetRx, Hygieai
Sep 7, 2024
|
2 Min Read
byRichard Daverman
Innovation
Eyes on Asia: UCB portfolio sale, Navigator bags $100m, Bora bulks out CDMO biz
Eyes on Asia: UCB portfolio sale, Navigator bags $100m, Bora bulks out CDMO biz
Sep 1, 2024
|
3 Min Read
byRichard Daverman
Investment
Eyes on Asia: Mulititude out licenses, Huadong bulks up Abs, Merck and Kelun
Eyes on Asia: Multitude out licenses, Huadong bulks up Abs, Merck and Kelun
Aug 25, 2024
|
3 Min Read
byRichard Daverman
Nov 18, 2024
Championing life sciences innovators with the ultimate Biotech, Healthtech and Medtech Networking & Pitching Event. With 8 incredible presenting stages for startup, growth stage and publicly listed Biotech, Healthtech, Medtech, TechBio, Digital Health and Deeptech companies.
Register

News from APAC

thumbnail
Hubs
Eyes on Asia: News from Sanofi, Bayer, AZ plus the return of VC?News from Sanofi, Bayer, AZ plus the return of VC?
byRichard Daverman
Sep 29, 2024
2 Min Read
Chinese flag — Photo
Investment
China biopharma faces a pause; how bad is it?China biopharma mid-2023 market summary
byRichard Daverman
Sep 21, 2024
4 Min Read
thumbnail
Investment
Eyes on Asia: Eisai $1.5bn pact, OcuMension & Alcon, TYK IPO and moreEyes on Asia: Eisai $1.5bn pact, OcuMension & Alcon, TYK IPO and more
byRichard Daverman
Sep 18, 2024
4 Min Read

Recommended

Partnering
Novo’s hunt for genetic med tech drove $600m NanoVation pact
Novo’s hunt for genetic med tech drove $600m NanoVation pact
Plenary at BIO-Europe in Munich
Investment
How industry trends are evolving biotech innovation in 2023
2023 industry trends that helped evolve biotech innovation
three member panel on stage
Innovation
‘Data matters most’ in biotech, and AI is here to help
‘Data matters most’ in biotech, and AI is here to help
Oct 23 - Dec 31, 2025
partneringONE’s first-in-class partnering technology powers global events and enhances your networking experience.
LEARN MORE
Subscribe to Our Newsletters
Stay updated and receive your insights for life sciences investment, innovation and partnering directly in your inbox.
Stay Updated